Investor Relations
Company Overview
iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.
The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines.
Upcoming Events
Annual Meeting of Stockholders
Mar 5, 2020 • 9:30am EST
Stock Information
Investor Contact Information
Company
iBio Inc.
600 Madison Avenue
Suite 1601
New York, NY 10022
T: 302-355-9452
ir@ibioinc.com
Investor Relations
Stephen Kilmer
T: 646-274-3580
skilmer@ibioinc.com
Transfer Agent
Continental Stock Transfer & Trust Company
17 Battery Place
New York, NY 10004
T: 212-509-4000
cstmail@continentalstock.com